Abstract
The screening of prostate cancer is usually based on serum prostate-specific antigen (PSA) level. However, PSA is a marker with low specificity and poor sensitivity for early diagnosis and risk stratification of prostate cancer. We performed a systematic review of publications that evaluated the accuracy and reliability of novel exosomal …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
